Safety and efficacy of target controlled infusion administration of propofol and remifentanil for moderate sedation in non-hospital dental practice.

Douglas Lobb Masoud MiriMoghaddam Don Macalister David Chrisp Graham Shaw Hollis Lai

Published in: Journal of dental anesthesia and pain medicine (2023)

According to the results of this study, no patients experienced adverse events during sedation, and all patients were kept at a moderate sedation level for a wide range of sedation times and differing procedures. The results showed that TCI pumps are safe and effective for administering propofol and remifentanil for moderate sedation in dentistry.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
mechanical ventilation
chronic kidney disease
primary care
prognostic factors
peritoneal dialysis
low dose
emergency department
patient reported outcomes
adverse drug
oral health